Pharma & Biotech
Ocugen Locks In Cash Runway to 2028 as Gene Therapy Platform Heads to Fort Lauderdale and Beyond
Ocugen has closed a $115 million convertible note offering that buys the biotech group more than two years of operating...
BioNTech’s Radical Overhaul: 1,860 Job Cuts, Factory Shutdowns, and a €532 Million Loss as Cancer Bet Takes Center Stage
The era of pandemic-era blockbuster revenues at BioNTech has come to a definitive end. The Mainz-based biotech is shuttering four...
AbCellera Nears Key Catalyst as Pipeline Candidates Advance
Shares of AbCellera Biologics have been on a tear, climbing nearly 11% on Monday to €3.88 and pushing year-to-date gains...
Novo Nordisk’s China Patent Pause and Washington Pivot Create a Split-Screen Reality
Novo Nordisk closed the week with a bang, its shares surging 6.7% to €35.16 on Friday. But beneath that single-day...
BioNTech’s May Gauntlet: Earnings, a Shareholder Vote, and an Insider Sale Set the Stage
The first half of May is shaping up as a critical inflection point for BioNTech, with the German biotech facing...
Bayer’s €7 Billion Insurance Policy: Shareholders Back a Capital Cushion for the Glyphosate Endgame
Bayer’s annual general meeting on April 24 was a study in contradictions. Major institutional investors praised CEO Bill Anderson’s restructuring...
BioNTech’s Tightrope Walk: Can Pipeline Progress Bridge the Revenue Gap?
The narrative around BioNTech has shifted decisively. The pandemic-era cash cow is fading, and the company is now racing to...
Novo Nordisk’s Teen Pill Win Offers a Rebound, But the Washington Game Is Shifting
Novo Nordisk’s shares staged a dramatic recovery on Friday, surging nearly 7% to close at €35.16, as investors seized on...
Siemens Healthineers Faces a Perfect Storm as Basel Conference Opens Against a Backdrop of Debt and Declining Shares
The irony could hardly be starker. As Siemens Healthineers kicks off the ECIO oncology conference in Basel today, showcasing the...
Bayer’s Two-Front Battle: A Supreme Court Pivot and a €7 Billion War Chest
Bayer enters a defining week with its stock under pressure, a Supreme Court hearing on the horizon, and shareholders having...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
